| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hematuria | D006417 | 13 associated lipids |
| Glomerulonephritis | D005921 | 35 associated lipids |
| Gastrointestinal Hemorrhage | D006471 | 27 associated lipids |
| Takotsubo Cardiomyopathy | D054549 | 1 associated lipids |
Total
4
6alpha-methylprednisolone
6alpha-methylprednisolone is a lipid of Sterol Lipids (ST) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 72234 references associated with 6alpha-methylprednisolone in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 6alpha-methylprednisolone
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 6alpha-methylprednisolone
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 6alpha-methylprednisolone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Aragon E et al. | Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis. | 2016 | Lupus | pmid:26537422 |
| Yesilipek MA et al. | Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study. | 2016 | Pediatr Transplant | pmid:26707539 |
| Capogrosso RF et al. | Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone. | 2016 | Pharmacol. Res. | pmid:26930420 |
| Müller-Deile J et al. | A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis. | 2015 | Eur. J. Clin. Invest. | pmid:26444294 |
| Fan F et al. | Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. | 2015 | Toxicol. Sci. | pmid:25752796 |
| Li MX et al. | Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy. | 2015 | Genet. Mol. Res. | pmid:25867415 |
| Hurlbert RJ et al. | Pharmacological therapy for acute spinal cord injury. | 2015 | Neurosurgery | pmid:25692371 |
| Zhang X et al. | Increased levels of tumor necrosis factor-α involved in rituximab-related acute pulmonary fibrosis in diffuse large B-cell lymphoma. | 2015 | Am. J. Clin. Pathol. | pmid:25873507 |
| PytlÃk R et al. | Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial. | 2015 | Leuk. Lymphoma | pmid:24628294 |
| Yokoyama H et al. | Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR). | 2015 | Clin. Exp. Nephrol. | pmid:25230687 |